Company Search:
Advanced Search
Sponsored Links
Samsung Pharmaceutical Co Ltd Company Snapshot
Samsung Pharmaceutical Co Ltd operates within the Pharmaceutical preparations sector. In addition to historical fundamental analyses, the complete report available to purchase compares Samsung Pharmaceutical Co Ltd with three other companies in this sector in South Korea: Aprogen Pharmaceuticals Inc (2018 sales of 45.40 billion Korean Won [US$38.13 million] of which 1% was Merchandise), Ildong Holdings Co Ltd (47.05 billion Korean Won [US$39.52 million] of which 30% was Holdings), and Jin Yang Pharmaceuticals Co Ltd (46.86 billion Korean Won [US$39.36 million] ).

Sales Analysis. During the year ended December of 2018, sales at Samsung Pharmaceutical Co Ltd were 46.48 billion Korean Won (US$39.05 million). This is an increase of 10.9% versus 2017, when the company's sales were 41.92 billion Korean Won. Despite this increase, sales are still below the level achieved in 2016, when Samsung Pharmaceutical Co Ltd reported sales of 48.22 billion Korean Won. The sales level in 2018 was fairly close to the level five years ago: in 2013, Samsung Pharmaceutical Co Ltd had sales of 46.92 billion Korean Won. Sales of Health Food Segment saw an increase that was more than double the company's growth rate: sales were up 22.7% in 2018, from 3.03 billion Korean Won to 3.72 billion Korean Won.
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
Samsung Pharmaceutical Co Ltd
  Stock Performance Chart for Samsung Pharmaceutical Co Ltd
  Stock Data: Recent Stock Performance:
  Current Price (11/29/2019): 4,060.00
(Figures in Korean Won)
1 Week -4.7%   13 Weeks -7.3%  
4 Weeks 32.0%   52 Weeks 47.1%  
Samsung Pharmaceutical Co Ltd Key Data:
  Ticker: 001360 Country: Korea (South)
  Exchanges: SEO Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Pharmaceutical Preparations
  2018 Sales 46,483,649,019
(Year Ending Jan 2019).
Employees: 205
  Currency: Korean Won Market Cap: 237,791,536,640
  Fiscal Yr Ends: December Shares Outstanding: 58,569,344
  Share Type: Common Closely Held Shares: 8,130,356
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.